Oncolytic viral therapy using reovirus

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 607-634

  Thirukkumaran, Chandini ^a   Morris, Don G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cancer; clinical trials; oncolytic viruses; reovirus

Indexed keywords

ORTHOREOVIRUS; RNA VIRUSES;

CLINICAL TRIAL; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; ONCOLYTIC VIROTHERAPY; PHYSIOLOGY; REOVIRUS; REVIEW; VIROLOGY; VIRUS INFECTION;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; REOVIRIDAE; REOVIRIDAE INFECTIONS;

EID: 67650296739     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_31     Document Type: Article

References (91)

1. Butel JS.2000) Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease Carcinogenesis; 21 : 405-426
2. DePace N.1921) Sulla comparsa di un enorme cancro vegetante del collo dell'utero senza cura chirurgica Ginecologia; 9 : 82-89
3. Bluming AZ , Ziegler JL.1971) Regression of Burkitt's lymphoma in association with measles infection Lancet; 2 : 105-106
4. Taqi AM , Abdurrahman MB , Yakubu AM , Fleming AF.1981) Regression of Hodgkin' disease after measles Lancet; 1 : 1112
5. Moore AE.1954) Effects of viruses on tumors Annu Rev Microbiol; 8 : 393-410
6. Sinkovics J , Horvath J.1993) New developments in the virus therapy of cancer: a historical review Intervirology; 36 : 193-214
7. Nibert M , Shiff L.2001) Reoviruses and their replication In: Knipe DM , Howley PM , editors. Fields Virology Philadelphia, PA : Lippincott-Raven
8. Weiner HL , Fields BN.1977) Neutralization of reovirus: the gene responsible for the neutralization antigen J Exp Med; 146 : 1305-1310
9. Ramos-Alvarez M , Sabin AB.1954) Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children Proc Soc Exp Biol Med; 87 : 655-661
10. Sabin AB.1959) Reoviruses A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described. Science; 130 : 1387-1389
11. Rosen L.1960) Serologic grouping of reoviruses by hemagglutination- inhibition Am J Hyg; 71 : 242-249
12. Rosen L , Hovis JF , Mastrota FM , Bell JA , Huebner RJ.1960) Observations on a newly recognized virus (Abney) of the reovirus family Am J Hyg; 71 : 258-265
13. Cashdollar LW , Chmelo RA , Wiener JR , Joklik WK.1985) Sequences of the S1 genes of the three serotypes of reovirus Proc Natl Acad Sci USA; 82 : 24-28
14. Duncan R , Horne D , Cashdollar LW , Joklik WK , Lee PW.1990) Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus Virology; 174 : 399-409
15. Atwater JA , Munemitsu SM , Samuel CE.1986) Biosynthesis of reovirus-specified polypeptides. Molecular cDNA cloning and nucleotide sequence of the reovirus serotype 1 Lang strain s4 mRNA which encodes the major capsid surface polypeptide sigma 3 Biochem Biophys Res Commun ; 136 : 183-192
16. Tarlow O , McCorquodale JG , McCrae MA.1988) Molecular cloning and sequencing of the gene (M2) encoding the major virion structural protein (mu 1-mu 1C) of serotypes 1 and 3 of mammalian reovirus Virology; 164 : 141-146
17. Dermody TS , Schiff LA , Nibert ML , Coombs KM , Fields BN.1991) The S2 gene nucleotide sequences of prototype strains of the three reovirus serotypes: characterization of reovirus core protein sigma 2 J Virol; 65 : 5721-5731
18. Zou S , Brown EG.1992) Nucleotide sequence comparison of the M1 genome segment of reovirus type 1 Lang and type 3 Dearing Virus Res; 22 : 159-164
19. Sranley NF , Dorman DC , Ponsford J.1953) Studies on the pathogenesis of hitherto undescribed virus (hepato-encephalomyelitis) producing unusual symptoms in suckling mice Aust J Exp Biol Med Sci ; 31 : 147-159
20. Saito T , Shinozaki K , Matsunaga T et al.2004) Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct J Hepatol; 40 : 203-211
21. Loken SD , Norman K , Hirasawa K , Nodwell M , Lester WM , Demetrick DJ.2004) Morbidity in immunosuppressed (SCID/NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic Cancer Biol Ther; 3 : 734-738
22. Hirasawa K , Nishikawa SG , Norman KL , Alain T , Kossakowska A , Lee PW.2002) Oncolytic reovirus against ovarian and colon cancer Cancer Res; 62 : 1696-1701
23. Rosen L , EVans HE , Spickard A.1963) Reovirus infections in human volunteers Am J Hyg; 77 : 29-37
24. Johansson PJ , Sveger T , Ahlfors K , Ekstrand J , Svensson L.1996) Reovirus type 1 associated with meningitis Scand J Infect Dis; 28 : 117-120
25. Joske RA , Keall DD , Leak PJ , Stanley NF , Walters MN.1964) Hepatitis-encephalitis in humans with reovirus infection Arch Intern Med; 113 : 811-816
26. Strong JE , Tang D , Lee PW.1993) Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency Virology; 197 : 405-411
27. Tang D , Strong JE , Lee PW.1993) Recognition of the epidermal growth factor receptor by reovirus Virology; 197 : 412-414
28. Strong JE , Lee PW.1996) The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection J Virol; 70 (1) : 612-616
29. Campbell SL , Khosravi-Far R , Rossman KL , Clark GJ , Der CJ.1998) Increasing complexity of Ras signaling Oncogene; 17 : 1395-1413
30. Bianco R , Melisi D , Ciardiello F , Tortora G.2006) Key cancer cell signal transduction pathways as therapeutic targets Eur J Cancer; 42 : 290-294
31. Strong JE , Coffey MC , Tang D , Sabinin P , Lee PW.1998) The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus EMBO J; 17 : 3351-3362
32. Mundschau LJ , Faller DV.1992) Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation J Biol Chem; 267 : 23092-23098
33. Mundschau LJ , Faller DV.1994) Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and rastransformed cells Biochimie; 76 : 792-800
34. Bischoff JR , Samuel CE.1989) Mechanism of interferon action. Activation of the human P1/ eIF-2 alpha protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA Virology ; 172 : 106-115
35. Panniers R , Henshaw EC.1983) A GDP/ GTP exchange factor essential for eukaryotic initiation factor 2 cycling in Ehrlich ascites tumor cells and its regulation by eukaryotic initiation factor 2 phosphorylation J Biol Chem; 258 : 7928-7934
36. Norman KL , Hirasawa K , Yang AD , Shields MA , Lee PW.2004) Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection Proc Natl Acad Sci U S A; 101 : 11099-11104
37. Hashiro G , Loh PC , Yau JT.1977) The preferential cytotoxicity of reovirus for certain transformed cell lines Arch Virol; 54 : 307-315
38. Duncan MR , Stanish SM , Cox DC.1978) Differential sensitivity of normal and transformed human cells to reovirus infection J Virol; 28 : 444-449
39. Coffey MC , Strong JE , Forsyth PA , Lee PW.1998) Reovirus therapy of tumors with activated Ras pathway Science; 282 : 1332-1334
40. Connolly JL , Rodgers SE , Clarke P et al.2000) Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB J Virol; 74 : 2981-2989
41. Clarke P , Meintzer SM , Spalding AC , Johnson GL , Tyler KL.2001) Caspase 8-dependent ensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection Oncogene; 20 : 6910-6919
42. Clarke P , Tyler KL.2007) Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAILinduced apoptosis Apoptosis; 12 : 211-223
43. Smakman N , Van den Wollenberg DJ , Elias SG et al.2006) KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand Cancer Res; 66 : 5403-5408
44. Thirukkumaran C, Shi ZH, Spurrell J, Thirukkumaran P, Morris D.2007) Breast cancer oncolysis by reovirus is mediated through upregulation of PUMA and NF-kB proteins of the apoptotic signalling pathway [abstract]. In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; AACR; 2007. 48. Abstract nr. 1929.
45. Thirukkumaran C, Thirukkumaran P, Morris D.2005) Gene expression profiling of reovirus oncolysis in breast cancer [abstract]. In: Proceedings of the 96th Annual Meeting of the American Association for Cancer Research; AACR; 2005. 46. Abstract nr. 24.
46. Wilcox ME , Yang W , Senger D et al.2001) Reovirus as an oncolytic agent against experimental human malignant gliomas J Natl Cancer Inst; 93 : 903-912
47. Norman KL , Coffey MC , Hirasawa K et al.2002) Reovirus oncolysis of human breast cancer Hum Gene Ther; 13 : 641-652
48. Kilani RT , Tamimi Y , Hanel EG et al.2003) Selective reovirus killing of bladder cancer in a co-culture spheroid model Virus Res; 93 : 1-12
49. Etoh T , Himeno Y , Matsumoto T et al.2003) Oncolytic viral therapy for human pancreatic cancer cells by reovirus Clin Cancer Res; 9 : 1218-1223
50. Nodwell M, Thirukkumaran CM, Luider J et al.2000) Reovirus as a novel prostate cancer therapeutic. American Association for Cancer Research (AACR) 91st annual meeting proceedings 41, Abstract nr. 122. 2000.
51. Alain T , Hirasawa K , Pon KJ et al.2002) Reovirus therapy of lymphoid malignancies Blood; 100 : 4146-4153
52. Thirukkumaran CM , Luider JM , Stewart DA et al.2003) Reovirus oncolysis as a novelpurging strategy for autologous stem cell transplantation Blood; 102 : 377-387
53. Libermann TA , Nusbaum HR , Razon N et al.1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature; 313 : 144-147
54. Guha A , Dashner K , Black PM , Wagner JA , Stiles CD.1995) Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop Int J Cancer; 60 : 168-173
55. Yang WQ , Lun X , Palmer CA et al.2004) Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates Clin Cancer Res; 10 : 8561-8576
56. Forsyth P, Roldan G, George D et al.2008) A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol Ther; 16(3):627-632.
57. Rutka JT.1997) Medulloblastoma Clin Neurosurg; 44 : 571-585
58. Yang WQ , Senger D , Muzik H et al.2003) Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma Cancer Res; 63 : 3162-3172
59. Morris DG, Forsyth PA, Paterson AH et al.2002) A phase 1 clinical trial evalutating entralesional REOLYSIN (reovirus) in histologically confirmed malignancies [abstract]. In: Proceedings of American Society of Clinical Oncology; ASCO; 2002. 21. p 24a. Abstract nr. 92.
60. Dankort DL , Wang Z , Blackmore V , Moran MF , Muller WJ.1997) Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation Mol Cell Biol; 17 : 5410-5425
61. Slamon DJ , Godolphin W , Jones LA et al.1989) Studies of the HER-2/neu protooncogene in human breast and ovarian cancer Science; 244 : 707-712
62. DeFazio A , Chiew YE , Sini RL , Janes PW , Sutherland RL.2000) Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines Int J Cancer; 87 : 487-498
63. Russello SV , Shore SK.2003) Src in human carcinogenesis Front Biosci; 8 : 1068-1073
64. Biscardi JS , Ishizawar RC , Silva CM , Parsons SJ.2000) Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer Breast Cancer Res; 2 : 203-210
65. Prenzel N , Zwick E , Leserer M , Ullrich A.2000) Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification Breast Cancer Res ; 2 : 184-190
66. Yang WQ , Senger DL , Lun XQ et al.2004) Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer Gene Ther; 11 : 1579-1589
67. Bos JL.1989) ras oncogenes in human cancer: a review Cancer Res; 49 : 4682-4689
68. Smakman N , Van der Bilt JD , Van den Wollenberg DJ , Hoeben RC , Borel R , I , Kranenburg O.2006) Immunosuppression promotes reovirus therapy of colorectal liver metastases Cancer Gene Ther; 13 : 815-818
69. Hanel EG , Xiao Z , Wong KK , Lee PW , Britten RA , Moore RB.2004) A novel intravesical therapy for superficial bladder cancer in an orthotopic model: oncolytic reovirus therapy J Urol; 172 : 2018-2022
70. Almoguera C , Shibata D , Forrester K , Martin J , Arnheim N , Perucho M.1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell; 53 : 549-554
71. Himeno Y , Etoh T , Matsumoto T , Ohta M , Nishizono A , Kitano S.2005) Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models Int J Oncol; 27 : 901-906
72. Hirasawa K , Nishikawa SG , Norman KL et al.2003) Systemic reovirus therapy of metastatic cancer in immune-competent mice Cancer Res; 63 : 348-353
73. Bebb G, Muzik H, Alain T et al.2005) Treatment of intermediate subviral particles overcomes resistance to reovirus induced oncolysis in mantle cell ymphoma cell lines [abstract]. In: Proceedings of the 47th Annual Meeting and Exposition of the American Society of Hematology; Blood; 2005. 106. Abstract nr. 2417.
74. Errington F, Coffey M, Hatfield P, Harrington K, Melcher AA.2005) Potential role for reovirus in the treatment of melanoma: Targeted killing and immune stimulation [abstract]. In: Proceedings of the 96th Annual Meeting of the American Association for Cancer Research; 2005; AACR; 46. Abstract nr. 6040.
75. Zhang WE, Anders Kolb E.2006) Reolysin, an unmodified reovirus, has significant antitumour activity in childhood sarcomas [abstract]. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006; AACR; 47. Abstract nr. 4331.
76. Lane ME, Fahey JM, Besanceney C et al.2007) In vivo synergy between oncolytic reovirus and gemicitabine in ras-mutated human HCT-116 xenografts [abstract]. In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; 2007; AACR; 48. Abstract nr. 4812.
77. Walder S , Yu B , Lane M et al.2004) The oncolytic reovirus, Reolysin, augments the anticancer effects of cytotoxic agents in vitro against the ras-mutated human colon cancer cell line HCT 116 Eur J Cancer Suppl 2 : 8
78. Sei S , Yang Q , Mussio J et al.2007) Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents against non-small cell lung cancer (NSCLC) European Journal of Cancer Supplements; 4 : 103
79. Heinemann L, Harrington KJ, Coffey M, Thompson B, Parker HS, Pandha HS.2007) Synergistic antitumour activity of oncolytic reovirus and cisplatin in malignant melanoma [abstract]. In: The 4th international conference on oncolytic viruses as cancer therapeutics; 2007.
80. Vidal L , Twigger K , White C , Coffey M , Thompson B , De-Bono J , Pandha HS , Melcher A , Kaye S , Harrington KJ.2005) Reovirus enhances radiation cytotoxicity in vitro and in vivo Clinical Cancer Research ; 11 : 23 Suppl Abs A170
81. Deisseroth AB , Zu Z , Claxton D et al.1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood; 83 : 3068-3076
82. Thirukkumaran CM , Luider JM , Stewart DA et al.2005) Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts Bone Marrow Transplant; 35 : 1055-1064
83. Vile R.2007) Oncolytic virotherapy and T cells: Friends, foes or ferries? In: The 4th international conference on oncolytic viruses as cancer therapeutics; 2007.
84. Errington F, Harrington KJ, Pandha HS et al.2006) Reovirus activates dendritic cell (DC) and promotes innate Anti-Tumour immunity. In: 1st Joint Meeting of European National Societies of Immunology; 2006.
85. Fraser S, Merrick A, Errington F, Selby P, Toogood G, Melcher A.2007) Reovirus as a potentially immunogenic as well as cytotoxic therapy for metastatic colorectal cancer. In: Proceedings of the Society of Academic & Research Surgery conference; 2007.
86. Errington F, Coffey M, Hatfield P, Harrington K, Melcher AA.2005) Potential role for reovirus in the treatment of melanoma: Targeted killing and immune stimulation [abstract]. In: Proceedings of the 96th Annual Meeting of the American Association for Cancer Research; 2005; AACR; 46. Abstract nr. 6040.
87. Dermody TS.1998) Molecular mechanisms of persistent infection by reovirus Curr Top Microbiol Immunol 212 : 272-276
88. Alain T , Kim M , Johnston RN et al.2006) The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro Br J Cancer; 95 : 1020-1027
89. Kim M , Egan C , Alain T et al.2007) Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells Oncogene; 26 : 4124-4134
90. Vidal L, Pandha HS, Yap TA et al.2008) A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res; 14(21):7127-7137.
91. Vidal L, Twigger K, White CL et al.2006) Phase I trial of intratumoral administration of reovirus type 3 (Reolysin) in combination with radiation in patients with adVanced malignancies. [Abstract]. In: Proceedings of the 97 th annual meeting of the American Association for Cancer Research; 2006; 47. Abstract nr. 3998.